2017
DOI: 10.1159/000484215
|View full text |Cite
|
Sign up to set email alerts
|

Eryptosis - the Neglected Cause of Anemia in End Stage Renal Disease

Abstract: End stage renal disease (ESRD) invariably leads to anemia which has been mainly attributed to compromised release of erythropoietin from the defective kidneys with subsequent impairment of erythropoiesis. However, erythropoietin replacement only partially reverses anemia pointing to the involvement of additional mechanisms. As shown more recently, anemia of ESRD is indeed in large part a result of accelerated erythrocyte loss due to suicidal erythrocyte death or eryptosis, characterized by cell shrinkage and c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
43
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 47 publications
(45 citation statements)
references
References 150 publications
0
43
0
2
Order By: Relevance
“…Thus, these observations indicate that anemia in ESRD is, in large part, due to accelerated clearance of circulating erythrocytes in the blood stream resulting from increased stimulation of eryptosis and remains refractory to therapeutic overcompensation of erythropoietin deficiency .…”
Section: Clinical Conditions Stimulating Eryptosis By Generation Of Omentioning
confidence: 96%
“…Thus, these observations indicate that anemia in ESRD is, in large part, due to accelerated clearance of circulating erythrocytes in the blood stream resulting from increased stimulation of eryptosis and remains refractory to therapeutic overcompensation of erythropoietin deficiency .…”
Section: Clinical Conditions Stimulating Eryptosis By Generation Of Omentioning
confidence: 96%
“…Several inbitors of eryptosis have been identified [88][89][90][91]. Eryptosis is enhanced in several clinical conditions including iron deficiency [33], dehydration [33], hyperphosphatemia [33], vitamin D excess [33], chronic kidney disease (CKD) [92][93][94][95][96][97], hemolytic-uremic syndrome [98], autoimmune hemolytic anemia [99], diabetes [33], hypertension and dyslipidemia [100], hepatic failure [101], malignancy [102][103][104], arteritis [105], systemic lupus erythematosus [106], sepsis [107,108], malaria [33,109,110], sickle-cell disease [33], beta-thalassemia [33], Hb-C and G6PD-deficiency [33], Wilsons disease [107], as well as advanced age [33]. Eryptosis is fostered by storage for transfusion [41,42,58,111].…”
Section: Introductionmentioning
confidence: 99%
“…Además, pueden adherirse a la pared vascular y perjudicar la microcirculación. Entre los estimuladores de la eriptosis están el complemento, los estados hiperosmóticos, la falta de calorías, el estrés oxidativo, los xenobióticos, (28,29) las toxinas urémicas, la eritropoyetina y las hemodiálisis .…”
Section: Discussionunclassified